View of Omega 3 supplementation to reduce alpha threonine kinase 1 (AKT1) levels in children with acute lymphoblastic leukemia (ALL) in the induction phase of chemotherapy

Return to Article Details Omega 3 supplementation to reduce alpha threonine kinase 1 (AKT1) levels in children with acute lymphoblastic leukemia (ALL) in the induction phase of chemotherapy Download Download PDF